Kano, Yosuke
Ohashi, Manabu
Hiki, Naoki
Takahari, Daisuke
Chin, Keisho
Yamaguchi, Kensei
Ida, Satoshi
Kumagai, Koshi
Sano, Takeshi
Nunobe, Souya
Article History
Received: 5 January 2020
Accepted: 6 March 2020
First Online: 2 April 2020
Compliance with ethical standards
:
: Takeshi Sano received honoraria from Taiho Pharmaceutical, Chugai Pharmaceutical, Ono Pharmaceutical, MSD and Eli Lilly; Kensei Yamaguchi received honoraria from Takeda Pharmaceutical Company Limited, Bayer, Daiichi-Sankyo, Sanofi, Dainippon-Sumitomo, MSD and Gilead and received research finding from Taiho Pharmaceutical, Eli Lilly, Ono Pharmaceutical, Bristol-Myers Squibb, Yakult and Chugai Pharmaceutical; Daisuke Takahari received honoraria from Eli Lilly, Brustol-Myers Squibb, Yakult and Chugai Pharmaceutical, and received research finding from Taiho Pharmaceutical and Ono Pharmaceutical.